Arvida Group completion of shortfall bookbuild finally confirmed
AUCKLAND: Arvida Group Limited (NZX: ARV) has completed the shortfall bookbuild component of its $175… read more
Clinuvel facing second strike and board spill
MELBOURNE: Clinuvel Pharmaceuticals – a market darling which has developed a drug for a rare… read more
PolyNovo feels the burn as CEO resigns suddenly
SYDNEY: Shares in burns treatment specialist PolyNovo dropped sharply following the announcement managing director Paul… read more
Ansell in sweet spot for private equity buyout
MELBOURNE: Ansell’s global rivals have recently signalled that acquisitions are on the agenda, leading some… read more
